| ▲ | Early progress on accelerating drug development with Claude(anthropic.com) |
| 43 points by dataking an hour ago | 27 comments |
| |
|
| ▲ | ruther4d 17 minutes ago | parent | next [-] |
| > Six Generate scientists used Claude Code to propose new designs for this part “Generate scientist” … is that a real job like “prompt engineer” |
| |
| ▲ | anigbrowl 7 minutes ago | parent | next [-] | | I think the dividing line between skilled and unskilled use of AI is 'machine, do magic' vs 'machine, do x, y and Z, thus and so, avoid i, j, k which knowledge is the fruit of bitter experience.' Being able to articulate what matters and why is the ultimate high level language. | |
| ▲ | traceroute66 13 minutes ago | parent | prev [-] | | "Invent a new drug, make no mistakes" | | |
| ▲ | mysterydip 3 minutes ago | parent [-] | | “One that won't make me nervous, wondering what to do.
One that makes me feel like I feel when I'm with you.” |
|
|
|
| ▲ | adamredwoods an hour ago | parent | prev | next [-] |
| I have a rare disease with no cure. Id love to see how Claude can help with us, but I'm cautious what it can really advance. Murine models still take time, and clinical trials are slow. I would think most biotech companies lose money at these stages. >> If Claude is to significantly increase the rate of new cures, we need to work with many more biotechnology firms and integrate Claude more deeply into their development processes Sounds invasive. |
| |
|
| ▲ | yewenjie 27 minutes ago | parent | prev | next [-] |
| TBH, I am waiting for Mathocalypse-level progress in biology and medicine, but I guess that's not happening as fast, because it's the real world, human lives, etc., mostly etc. |
| |
| ▲ | dennysora-main a few seconds ago | parent | next [-] | | Indeed, actually, one of the limitations preventing AI from making more contributions is humans. Human emotions, laws, morality, responsibility, and so on are all part of these limitations. I've always thought openai could actually create an agent that can control various physical robotic arms and things like that, and then continuously iterate on solutions that can participate in the real physical environment. This could accelerate automatic iteration for many things that require human operations, such as complicated experiments, assembly adjustments, and testing. Otherwise, AI is always trapped in virtual systems and still needs human intervention. But even though AI is already very powerful now, there is still a limit to how much humans can handle or assign tasks. Many times, AI has already finished processing something, but I don't even have time to assign the next deeper level of tasks. People hope AI can improve productivity, but at the same time they're afraid of AI actually getting involved in reality, while the valuation of the entire AI industry is so high. This kind of wanting to move forward but not moving forward makes humans especially uncomfortable. | |
| ▲ | xhevahir 15 minutes ago | parent | prev | next [-] | | I expect that AI use in the more axiomatic kinds of research will be well in advance of sciences that have a heavy, messy empirical foundation, like biology. | |
| ▲ | redanddead 20 minutes ago | parent | prev | next [-] | | That plus organs on a chip could be scalable and generate interesting data | |
| ▲ | slashdave 17 minutes ago | parent | prev | next [-] | | Keep waiting | |
| ▲ | enraged_camel 20 minutes ago | parent | prev [-] | | Specifically, it's because the verification loops are much longer in applied sciences. In biology you need to wait for wet lab experiments, clinical trials, regulatory steps, etc. before you can call something "solved". Since sequential steps are slow, I think we're going to see massive increases in parallelization. I'm not sure how the regulatory frameworks will keep up honestly. | | |
| ▲ | slashdave 16 minutes ago | parent | next [-] | | > we're going to see massive increases in parallelization Why? This is not an AI problem, it's an industry one. And if it was simple, it would already exist. | | |
| ▲ | menaerus 9 minutes ago | parent [-] | | > And if it was simple, it would already exist. Not necessarily. Many things are simply gatekept behind the door. |
| |
| ▲ | Bluestein 6 minutes ago | parent | prev [-] | | > wet lab experiments, clinical trials, regulatory steps I wonder what the unlock would be, if any, of having simulations substitute any (or all, in time) of these steps. Akin to the method used to train FSD cars, or robots.- |
|
|
|
| ▲ | ndom91 a few seconds ago | parent | prev | next [-] |
| Cocaine 2.0? |
|
| ▲ | jon128 21 minutes ago | parent | prev | next [-] |
| Crossing fingers for LSD 2.0 |
| |
|
| ▲ | 2001zhaozhao 35 minutes ago | parent | prev | next [-] |
| I like how there's a giant "chapter picker" pinned at the top of the web page, but there are only two chapters and the second chapter is a tiny blob at the end of the article. |
| |
|
| ▲ | fwlr 7 minutes ago | parent | prev | next [-] |
| Claude, you are a senior drug dealer. Get me my fix, make no mistakes. |
|
| ▲ | inglor_cz 16 minutes ago | parent | prev | next [-] |
| The point about finding problems in documented processes (Enveda: manufacturing and filings) is unexpected but interesting. One of our civilizational problems is that the sheer volume of documentation has slowly exceeded capabilities of humans to produce it reliably and without flaws. Same applies to construction projects, BTW. |
|
| ▲ | Sarkie 29 minutes ago | parent | prev | next [-] |
| New cocaine? |
| |
| ▲ | ChrisMarshallNY 10 minutes ago | parent [-] | | We've had "research chemicals" for a couple of decades. Some, do what it says on the tin. Some...not so much. The issue with any new chemical is full, comprehensive, regulated testing. Dodgy folks aren't really so good, with that last part. They use their customers as guinea pigs. |
|
|
| ▲ | josefritzishere 24 minutes ago | parent | prev [-] |
| [dead] |